RxDoctor Payments Data

Denise Wade

Primary Care · Waynesville, OHNPI 1376871970

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Boston Scientific at 58.4% of the total. Reporting peaked in 2024 at $2,171 and has fallen 95.9% since, to $88 in 2025.

$2,574in general payments, 2019–2025

Across 33 payments — averaging $78.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$2K
  • Amneal Pharmaceuticals LLC$238
  • AstraZeneca$236
  • Vertos Medical, Inc.$193
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$113
  • Otsuka America Pharmaceutical, Inc.$77
  • plus $214 from 5 others

What the payments were for

  • Travel & lodging$1,29650%
  • Food & beverage$1,27850%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,574 in reported general payments places this provider in the 85th percentile of 321 primary care providers in Ohio.

See all primary care providers in Ohio

Medicare billing

Part B allowed, 2024
$16,887
Medicare patients
104
Services billed
345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Carbidopa-LevodopaCarbidopa/Levodopa80$1,262
Primidone46$1,106
Carbidopa-Levodopa ErCarbidopa/Levodopa17$897
Propranolol Hcl59$852
Topiramate27$444
Pramipexole DihydrochloridePramipexole Di-Hcl17$381
Donepezil Hcl15$118

Paid to pharmacies, not to this prescriber.

Other primary care in Waynesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →